Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease

被引:101
作者
Dedkova, Elena N. [1 ]
Blatter, Lothar A. [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA
来源
FRONTIERS IN PHYSIOLOGY | 2014年 / 5卷
基金
美国国家卫生研究院;
关键词
inorganic polyphosphate; beta-hydroxybutyrate; poly-beta-hydroxybutyrate; cardiovascular disease; heart failure; mitochondrial permeability transition pore; KETONE-BODY METABOLISM; FATTY-ACID OXIDATION; PERMEABILITY TRANSITION PORE; NITRIC-OXIDE SYNTHASE; ESCHERICHIA-COLI; KETOGENIC DIET; MYOCARDIAL-INFARCTION; P-32; ORTHOPHOSPHATE; GLUCOSE-UTILIZATION; INSULIN-RESISTANCE;
D O I
10.3389/fphys.2014.00260
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We provide a comprehensive review of the role of beta-hydroxybutyrate (beta-OHB), its linear polymer poly-beta-hydroxybutyrate (PHB), and inorganic polyphosphate (polyP) in mammalian health and disease. beta-OHB is a metabolic intermediate that constitutes 70% of ketone bodies produced during ketosis. Although ketosis has been generally considered as an unfavorable pathological state (e.g., diabetic ketoacidosis in type-1 diabetes mellitus), it has been suggested that induction of mild hyperketonemia may have certain therapeutic benefits. beta-OHB is synthesized in the liver from acetyl-CoA by beta-OHB dehydrogenase and can be used as alternative energy source. Elevated levels of PHB are associated with pathological states. In humans, short-chain, complexed PHB (cPHB) is found in a wide variety of tissues and in atherosclerotic plaques. Plasma cPHB concentrations correlate strongly with atherogenic lipid profiles, and PHB tissue levels are elevated in type-1 diabetic animals. However, little is known about mechanisms of PHB action especially in the heart. In contrast to beta-OHB, PHB is a water-insoluble, amphiphilic polymer that has high intrinsic viscosity and salt-solvating properties. cPHB can form non-specific ion channels in planar lipid bilayers and liposomes. PHB can form complexes with polyP and Ca2+ which increases membrane permeability. The biological roles played by polyP a ubiquitous phosphate polymer with ATP-like bonds, have been most extensively studied in prokaryotes, however polyP has recently been linked to a variety of functions in mammalian cells, including blood coagulation, regulation of enzyme activity in cancer cells, cell proliferation, apoptosis and mitochondrial ion transport and energy metabolism. Recent evidence suggests that polyP is a potent activator of the mitochondrial permeability transition pore in cardiomyocytes and may represent a hitherto unrecognized key structural and functional component of the mitochondrial membrane system.
引用
收藏
页数:22
相关论文
共 227 条
  • [21] INORGANIC POLYPHOSPHATES IN THE ACQUISITION OF COMPETENCE IN ESCHERICHIA-COLI
    CASTUMA, CE
    HUANG, RP
    KORNBERG, A
    REUSCH, RN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) : 12980 - 12983
  • [22] CHANCE B, 1979, J BIOL CHEM, V254, P4764
  • [23] Polyphosphate is a cofactor for the activation of factor XI by thrombin
    Choi, Sharon H.
    Smith, Stephanie A.
    Morrissey, James H.
    [J]. BLOOD, 2011, 118 (26) : 6963 - 6970
  • [24] The Polyphosphate Kinase Gene ppk2 Is Required for Mycobacterium tuberculosis Inorganic Polyphosphate Regulation and Virulence
    Chuang, Yu-Min
    Belchis, Deborah A.
    Karakousis, Petros C.
    [J]. MBIO, 2013, 4 (03):
  • [25] Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects
    Clarke, Kieran
    Tchabanenko, Kirill
    Pawlosky, Robert
    Carter, Emma
    King, M. Todd
    Musa-Veloso, Kathy
    Ho, Manki
    Roberts, Ashley
    Robertson, Jeremy
    VanItallie, Theodore B.
    Veech, Richard L.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2012, 63 (03) : 401 - 408
  • [26] Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate
    Clarke, Kieran
    Tchabanenko, Kirill
    Pawlosky, Robert
    Carter, Emma
    Knight, Nicholas S.
    Murray, Andrew J.
    Cochlin, Lowri E.
    King, M. Todd
    Wong, Andrea W.
    Roberts, Ashley
    Robertson, Jeremy
    Veech, Richard L.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2012, 63 (02) : 196 - 208
  • [27] Ketone body metabolism and cardiovascular disease
    Cotter, David G.
    Schugar, Rebecca C.
    Crawford, Peter A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 304 (08): : H1060 - H1076
  • [28] COWLING RT, 1994, J BIOL CHEM, V269, P9480
  • [29] Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation
    Crawford, Peter A.
    Crowley, Jan R.
    Sambandam, Nandakumar
    Muegge, Brian D.
    Costello, Elizabeth K.
    Hamady, Micah
    Knight, Rob
    Gordon, Jeffrey I.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) : 11276 - 11281
  • [30] CROOKE E, 1994, J BIOL CHEM, V269, P6290